GALECTIN THERAPEUTICS INC ($GALT)
Filing Information
| Accession Number | 0001133416-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
180,000
Total Value
$232,402.06
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 60,000 | $0.00 | $0.00 | 60,000 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 2, 2026 | Sale | 13,055 | $4.20 | $54,789.22 | 46,945 | Direct | โ | View Details | |
Chief Medical Officer | Common stock | โ | Jan 5, 2026 | Sale | 25,499 | $3.90 | $99,407.85 | 21,446 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 6, 2026 | Sale | 21,446 | $3.65 | $78,204.98 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Unit | Derivative | Jan 1, 2026 | Exercise/Conversion | 60,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |